Koers Thermo Fisher Scientific Berne S.E.
Aandelen
TFS
US8835561023
Geavanceerde medische apparatuur & technologie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
514,5 CHF | -0,35% |
|
-0,35% | +19,58% |
Omzet 2024 * | 43,02 mld. 38,36 mld. 40,14 mld. | Omzet 2025 * | 46,11 mld. 41,11 mld. 43,02 mld. | Marktkapitalisatie | 218 mld. 195 mld. 204 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 6,12 mld. 5,45 mld. 5,71 mld. | Nettowinst (verlies) 2025 * | 6,92 mld. 6,17 mld. 6,45 mld. | EV/omzet 2024 * | 5,61 x |
Nettoschuld 2024 * | 23,19 mld. 20,68 mld. 21,64 mld. | Nettoschuld 2025 * | 19,14 mld. 17,06 mld. 17,85 mld. | EV/omzet 2025 * | 5,15 x |
K/w-verhouding 2024 * |
35,9
x | K/w-verhouding 2025 * |
30,8
x | Werknemers | - |
Dividendrendement 2024 * |
0,26% | Dividendrendement 2025 * |
0,28% | Vrij verhandelbaar | 86,04% |
Recentste transcriptie over Thermo Fisher Scientific
1 dag | -0,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-11-01 |
Director of Finance/CFO | 57 | 01-06-01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-11-01 |
C. Harris
BRD | Director/Board Member | 67 | 30-03-12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 01-03-22 |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,93% | 189 mld. | |
+26,11% | 151 mld. | |
+31,74% | 113 mld. | |
-0,15% | 64,02 mld. | |
+12,56% | 52,6 mld. | |
+1,85% | 49,85 mld. | |
-6,08% | 37,89 mld. | |
-0,94% | 34,92 mld. | |
+21,90% | 31,1 mld. |